Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey

Evelien Krumb, Karin Fijnvandraat, Michael Makris, Flora Peyvandi, Aislin Ryan, Angelos Athanasopoulos, Cedric Hermans

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey'. Together they form a unique fingerprint.

Medicine & Life Sciences